Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.
Ensuring that options for patients living with rare diseases aren’t scarce.
US Army combat veteran Luis Alvarez has developed a new drug delivery technology that can convert recombinant proteins into material-binding variants.
New approaches are underway for treating nonalcoholic steatohepatitis.
In this eBook, thought leaders from Cambrex discuss market opportunities, drug development challenges, and more.
Small-molecule Sb9 inhibitor targets both cancer and associated cells to suppress tumor growth in mice.
How can we get macromolecules across the intestinal epithelial barrier?
Vectura has more than 20 years’ experience in helping customers bring inhaled medicines to the market.
Mice with severed spinal cords walk again after gene therapy.
Ewoud van Tricht
Ewoud van Tricht explores three novel methods that could streamline the development of adenovirus vaccines for COVID-19 at Janssen.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Painted Cells and Scrambled Jigsaws
The Time is Now for Digitally Simplified Bioprocessing
ADCs: Still Room for Improvement!